Masivet for Dogs - 50mg & 150mg
Masivet (licensed as Kinavet in the USA) is a prescription-only tablet for use against Mast Cell Tumours in dogs.
Mast cell tumours in dogs (MCTs) are the most common cutaneous malignancies in dogs, accounting for 16% to 21% of all skin tumours. Mast cell tumours demonstrate a wide range of behaviours, appearance and patterns of progression – all of which make these tumours a challenge to treat.
Whilst surgery is always the first option and the cornerstone of MCT management, anti-cancer medical treatment is needed when complete surgical removal is not possible or where the tumour is highly aggressive or has already spread.
Masivet is regarded as safe enough to be used at home, and is given as a tablet once daily. Masivet acts against mast cell tumours, by inhibiting cell division, therefore preventing further development of the tumours. Not all dogs respond, but the results can be very helpfu...
Masivet for Dogs - 50mg & 150mg
Masivet (licensed as Kinavet in the USA) is a prescription-only tablet for use against Mast Cell Tumours in dogs.
Mast cell tumours in dogs (MCTs) are the most common cutaneous malignancies in dogs, accounting for 16% to 21% of all skin tumours. Mast cell tumours demonstrate a wide range of behaviours, appearance and patterns of progression – all of which make these tumours a challenge to treat.
Whilst surgery is always the first option and the cornerstone of MCT management, anti-cancer medical treatment is needed when complete surgical removal is not possible or where the tumour is highly aggressive or has already spread.
Masivet is regarded as safe enough to be used at home, and is given as a tablet once daily. Masivet acts against mast cell tumours, by inhibiting cell division, therefore preventing further development of the tumours. Not all dogs respond, but the results can be very helpful for others. Close veterinary supervision is recommended at all times.
Masivet is prescribed for the treatment of non-resectable (inoperable) high grade mast cell tumours (Patnaik grade 2 and grade 3) Masivet for Dogs is a highly targeted treatment designed to work specifically and selectively on key biological pathways that cause the growth and spread of mast cell tumours.
Masivet is an effective, well-tolerated and proven treatment - and it was the first cancer medicine in the UK to be approved and licensed by the VMD for the treatment of dogs. Masivet acts systemically and has been shown in clinical studies to induce tumour shrinkage and to significantly prolong time to MCT progression.
A Veterinary Prescription is required for Masivet
